Uwe Gottschalk.
Operating Partner · Keensight Capital · DDIF 2026 · The Savoy, London.
the Circle. · DDIF 2027 · London
What compounds.
What translates.
Who reaches the patient.
Less noise. More signal.
01
Every drug discovery leader is asked the same question. How does a hypothesis become a candidate. With the data that holds. The infrastructure between target identification and clinical candidate is being rebuilt around AI.
02
The white space is the room that holds the decision differently. Closed-door. By invitation. End-user led. No expo hall. No vendor pitch. A circle for the leaders building what compounds.
03
the Conversation. DDIF is that room. Senior drug discovery leadership convened around the work that translates. Target identification. AI-driven design. Computational chemistry. Translational science. Less noise. More signal.
04
Who attends. Senior faculty drawn from the leaders who own the portfolio, sign the IND and carry the decision. Announced in cadence with the programme.
Drug Discovery & Innovation Forum 2027
For decision makers from small biotech to large pharma.
The gap.
Drug discovery moves faster than the frameworks designed to govern it. AI-driven compound design generates candidates faster than medicinal chemistry can validate. Predictive toxicity models recommend lead optimisation paths no human would have chosen. The gap between algorithmic output and scientific accountability has never been formally named.
The Conversation.
DDIF convenes the leaders building the intelligence that closes that gap · across AI-driven design · computational chemistry · HTS and automation · translational science. The corridor where drug discovery ambition becomes clinical candidate · or breaks. The Conversation is where the leaders who carry the decision meet before the portfolio review does.
The decision.
What compounds. What translates. Who reaches the patient. Three questions the room must hold before the programme locks. For the leaders who own the portfolio, sign the IND and are accountable for the intelligence layer no one has formally governed.
Uwe Gottschalk.
Operating Partner · Keensight Capital · DDIF 2026 · The Savoy, London.
Faculty announced in cadence with the programme.
Uwe Gottschalk.
Operating Partner · Keensight Capital · DDIF 2026 · The Savoy, London.
"
AI alone will not accelerate science.
Christian Olsen · VP Strategy, Protein Therapeutics · Dotmatics — Luma · DDIF 2026
the Circle. forum · in the room
ddif.ai · the years before · by GBX Circle
DDIF 2026 · The Savoy
Klaus Baek Simonsen · Lundbeck · DDIF 2026
Rory Stark · Altos Labs · DDIF 2026
delegates · DDIF 2026
in the room · DDIF 2026
the conversation · DDIF 2026
Klaus Baek Simonsen · Lundbeck · DDIF 2026
delegate · forum floor · DDIF 2026
A selection of the companies whose senior leaders attended DDIF or are pre-qualified.
Organisations who have partnered DDIF or whose senior leaders attend.
the Circle. DDIF · Partner Positions
Partner packages and investment are shared directly.
Enter your access code to continue.
No access code? Request the prospectus →
Not the forum. The relationship.
Q 1
The briefing.
Pre-forum strategic briefing. The room. The roster. The reason.
Q 2
The forum.
DDIF held inside each forum of the Conversation. Two days. Closed-door. End-user led.
Q 3
The follow.
Named delegate follow-through. Curated meeting introductions.
Q 4
The intelligence.
Quarterly intelligence briefing from the Conversation Team.
A position. Not a placement.
the circle. · access
The prospectus is not public. Shared directly with the organisations that belong Who attends.
"Not an event. It is a tradition."
Uwe Gottschalk · Former CSO Lonza
The room. The conversations. The decisions.